<- Archives UCL - Programme d'études ->



Chimie pharmaceutique avancée et drug design [ WFARM2501 ]


3.0 crédits ECTS  20.0 h + 10.0 h   2q 

Teacher(s) Frédérick Raphaël ; Muccioli Giulio (coordinator) ; Lambert Didier ;
Language French
Place
of the course
Bruxelles Woluwe
Prerequisites

organic chemistry and medicinal chemistry

Main themes

The teacher(s) will discuss first the different techniques allowing the discovery of novel therapeutic targets (lipidomic ' proteomic ' deorphanization), second the methods allowing the identification of hits for a given molecular target (high-throughput screening ; computer assisted de novo drug design); finally the strategies allowing to optimize a hit ('hit to lead') will be discussed (structures-activity relationships ; docking; ')

Aims

At the end of the activity the student will be able to

  • Interpret, based on what was discussed in class, the results presented in a scientific paper dealing with the development of a novel drug
  • Suggest a strategy allowing to identify novel therapeutic targets
  • Suggest a strategy allowing to identify novel lead compounds for a given target (enzyme, receptor, ')
  • Suggest a strategy allowing to optimize the activity of a drug towards its target
Evaluation methods

a written exam and a presentation of a case-study based on a scientific paper

Content
  • Lipidomics applied to the discovery of novel targets
  • Exploring the proteome looking for novel targets :  the enzymes ' the receptors
  • Proteins as therapeutic target
    • Determination of their 3D structure
    • Role of protein's 3D models in drug design
  • The interest of establishing structure-activity relationships in drug design
Cycle et année
d'étude
> Master [120] in Pharmacy
Faculty or entity
in charge
> FARM


<<< Page précédente